Risk for Incident Hypertension Associated With Posttraumatic Stress Disorder in Military Veterans and the Effect of Posttraumatic Stress Disorder Treatment.
Risk for Incident Hypertension Associated With Posttraumatic Stress Disorder in Military Veterans and the Effect of Posttraumatic Stress Disorder Treatment.
复制标题
DOI:
10.1097/psy.0000000000000376
复制
发表时间:
2017
影响因子:
3.3
通讯作者:
Haskell S
中科院分区:
文献类型:
--
作者:
Burg MM;Brandt C;Buta E;Schwartz J;Bathulapalli H;Dziura J;Edmondson DE;Haskell S
PTSD increases cardiovascular disease and cardiovascular mortality risk. Neither the prospective relationship of PTSD to incident hypertension risk, nor the effect of PTSD treatment on hypertension risk has been established. Data from a nationally representative sample of 194,319 veterans were drawn from the Veterans Administration roster of United States service men and women. This included veterans whose end of last deployment was from September 2001 – July 2010, and whose first VA medical visit was from October 1, 2001 – January 1, 2009. Incident hypertension was modeled as 3 events: 1) a new diagnosis of hypertension; and/or 2) a new prescription for anti-hypertensive medication; and/or 3) a clinic BP reading in the hypertensive range (≥140mmHg/90mmHg, systolic/diastolic). PTSD diagnosis was the main predictor. PTSD treatment was defined as, 1) at least 8 individual psychotherapy sessions of ≥ 50min during any consecutive 6 months and/or 2) a prescription for SSRI medication. Over a median 2.4 year follow-up, the incident hypertension risk independently associated with PTSD ranged from HR=1.12 (95% CI 1.08 – 1.17, p<0.0001) to HR=1.30 (95% CI 1.26 – 1.34, p<0.0001). The interaction of PTSD and treatment revealed that treatment reduced the PTSD associated hypertension risk (e.g., from HR=1.44 [95% CI 1.38 – 1.50, p<0.0001] for those untreated, to HR=1.20 [95% CI 1.15 – 1.25, p<0.0001] for those treated). These results indicate that reducing the long term health impact of PTSD and the associated costs, may require very early surveillance and treatment.